THE COSTS OF HEMOPHILIA A IN ALGERIA: THE FIRST CROSS-SECTIONAL, MULTICENTER COST-OF-ILLNESS STUDY

被引:0
|
作者
Nekkal, S. [1 ]
Khedim, H. [2 ]
Mesli, N. [3 ]
Bioud, B. [4 ]
Cherif, N. [1 ]
Salhi, N. [5 ]
Benmegherbi, F. [6 ]
Aissaoui, A. [7 ]
机构
[1] Algiers Univ, Algiers, Algeria
[2] Roche, Algiers 16, Algeria
[3] Tlemcen Univ, Tilimsen, Algeria
[4] Setif Univ, Setif, Algeria
[5] Constantine Univ, Constantine, Algeria
[6] Algiers Univ, Algiers, Algeria
[7] Paris Dauphine Univ, PSL, Paris, France
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
POSC80
引用
收藏
页码:S102 / S102
页数:1
相关论文
共 50 条
  • [21] DIRECT COSTS OF TYPE 2 DIABETES: A BRAZILIAN COST-OF-ILLNESS STUDY
    Henriques, Ricardo Saad
    Steimbach, Laiza Maria
    Baptista, Deise Regina
    Lenzi, Luana
    Tonin, Fernanda S.
    Pontarolo, Roberto
    Wiens, Astrid
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (02) : 180 - 188
  • [22] Awareness of Surgical Costs: A Multicenter Cross-Sectional Survey
    Bade, Kim
    Hoogerbrug, Jonathan
    JOURNAL OF SURGICAL EDUCATION, 2015, 72 (01) : 23 - 27
  • [23] A review of caregiver costs included in cost-of-illness studies
    Mattingly, T. Joseph, II
    Diaz Fernandez, Valeria
    Seo, Dominique
    Melgar Castillo, Andrea I.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (07) : 1051 - 1060
  • [24] Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study
    da Silva, Nilceia Lopes
    Takemoto, Maira L. S.
    Damasceno, Alfredo
    Fragoso, Yara D.
    Finkelsztejn, Alessandro
    Becker, Jefferson
    Goncalves, Marcus V. M.
    Tilbery, Charles
    de Oliveira, Enedina M. L.
    Callegaro, Dagoberto
    Boulos, Fernanda C.
    BMC HEALTH SERVICES RESEARCH, 2016, 16
  • [25] Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study
    Nilceia Lopes da Silva
    Maira L. S. Takemoto
    Alfredo Damasceno
    Yara D. Fragoso
    Alessandro Finkelsztejn
    Jefferson Becker
    Marcus V. M. Gonçalves
    Charles Tilbery
    Enedina M. L. de Oliveira
    Dagoberto Callegaro
    Fernanda C. Boulos
    BMC Health Services Research, 16
  • [26] Drug costs in context: assessing drug costs in cost-of-illness analyses
    Mattingly II, T. Joseph
    Weathers, Shannon
    DRUGS IN CONTEXT, 2022, 11
  • [27] Direct and indirect costs during the first year in recent-onset rheumatoid arthritis: A cost-of-illness study
    Hallert, E
    Husberg, M
    Jonsson, D
    Schmidt, A
    Thyberg, I
    Skogh, T
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 354 - 355
  • [28] Societal costs of subclinical depressive symptoms in Dutch adolescents: a cost-of-illness study
    Bodden, Denise H. M.
    van den Heuvel, Marieke W. H.
    Engels, Rutger C. M. E.
    Dirksen, Carmen D.
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2022, 63 (07) : 771 - 780
  • [29] DIRECT AND PRODUCTIVITY COSTS OF RHEUMATOID ARTHRITIS IN THE SLOVAK REPUBLIC - COST-OF-ILLNESS STUDY
    Dolezal, T.
    Klimes, J.
    Vocelka, M.
    VALUE IN HEALTH, 2012, 15 (07) : A443 - A443
  • [30] Attributable Costs of Lung Cancer for the Colombian Health System: A Cost-of-Illness Study
    Torres, Gabriel F.
    Amaya, Javier A.
    Buitrago, Giancarlo
    VALUE IN HEALTH REGIONAL ISSUES, 2022, 30 : 120 - 126